Oculis S.A., announces the completion of enrollment for stage 1 of its Phase III DIAMOND (DIAbetic Macular edema patients ON a Drop) study evaluating the efficacy and safety of OCS 01 in ppatients with diabetic macular edema (DME)
Disappointing data from a trial of the last remaining drug in its pipeline means that Oxurion (formerly known as ThromboGenics) is closing its doors after more than 30 years
scPharmaceuticals Inc., announced the Company received a Complete Response Letter (CRL) from the FDA regarding the 505(b)(2) application for Furoscix,...
Senju Pharmaceutical and Kidswell Bio said on January 13 that their biosimilar version of the ophthalmic vascular endothelial growth factor (VEGF) inhibitor Lucentis (ranibizumab) has added a new indication of diabetic macular edema
The FDA on 10 August 2012 approved Lucentis (ranibizumab injection) from Genentech for the treatment of Diabetic Macular Edema (DME),...
Allergan, Inc. has announced that the European Commission has extended the Marketing Authorization for Ozurdex (dexamethasone 700 mcg intravitreal implant...
Bausch Health Companies Inc. and Bausch + Lomb, its leading global eye health business, along with Clearside Biomedical, Inc. announced that the FDA has accepted the re-submitted New Drug Application for Xipere (triamcinolone acetonide suprachoroidal injectable suspension).
The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted market authorization for Eylea 8 mg (aflibercept 8 mg) for the treatment of neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Roche has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Vabysmo (faricimab) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and visual impairment due to diabetic macular edema (DME).
Bayer HealthCare has announced that aflibercept solution for injection into the eye has been recommended for approval by the European...